Polpharma Overview

  • Year Founded
  • 1935

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5,600

Employees

  • Latest Deal Type
  • Capital Spending

  • Financing Rounds
  • 8

  • Investments
  • 8

Polpharma General Information

Description

Manufacturer of generic drugs focused on helping people to live a healthy life in a healthy world. The company manufactures prescription drugs and pharmaceuticals for in-patient care and also specializes in pharmaceutical preparations used in cardiology, gastroenterology and neurology, enabling patients healthy and long life.

Contact Information

Website
www.polpharma.pl
Formerly Known As
Zaklady Farmaceutyczne Polpharma S.A.
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • Pelplińska 19
  • Starogard Gdanski, 83-200
  • Poland
+48 58
Primary Industry
Pharmaceuticals
Parent Company
Spectra Management
Vertical(s)
Manufacturing
Corporate Office
  • Pelplińska 19
  • Starogard Gdanski, 83-200
  • Poland
+48 58

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Polpharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Polpharma‘s full profile, request access.

Request a free trial

Polpharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of generic drugs focused on helping people to live a healthy life in a healthy world. The company manufactu
Pharmaceuticals
Starogard Gdanski, Poland
5,600 As of 2025

Mumbai, India
 

Mumbai, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Polpharma Competitors (15)

One of Polpharma’s 15 competitors is Alkem Laboratories, a Formerly PE-Backed company based in Mumbai, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alkem Laboratories Formerly PE-Backed Mumbai, India
Sun Pharmaceutical Industries Corporation Mumbai, India
Protek (Distribution & Retail) Corporate Backed or Acquired Moscow, Russia
Novartis Corporation Basel, Switzerland
Akrikhin Pharmaceuticals Corporate Backed or Acquired Moscow, Russia
You’re viewing 5 of 15 competitors. Get the full list »

Polpharma Patents

  • 237

    Total Documents Applications and Grants

  • Total Patents Families

  • 69

    Granted

  • 29

    Pending

  • Expiring in next 12 mo

Polpharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4778508-A1 Cosmetic composition for stimulating eye hair growth Pending 15-Jan-2025
WO-2026139588-A1 Ophtalmic pharmaceutical compositions for the treatment of conjunctivitis Pending 23-Dec-2024
WO-2026068706-A1 Thermal sterilisation of an antisense oligonucleotide Pending 27-Sep-2024
EP-4487910-A1 Process for the preparation of dapagliflozin Inactive 06-Jul-2023
EP-4739697-A1 Process for the preparation of dapagliflozin Pending 06-Jul-2023 C07H7/04
To view Polpharma’s complete patent history, request access »

Polpharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Polpharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Polpharma‘s full profile, request access.

Request a free trial

Polpharma Investments & Acquisitions (8)

Polpharma’s most recent deal was a Merger/Acquisition with Biofarm for . The deal was made on 21-Jul-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Biofarm 21-Jul-2026 Merger/Acquisition Pharmaceuticals
Bioeq (Zug) 22-Dec-2017 Joint Venture Pharmaceuticals
Santo Holding & Polpharma (Joint Venture) 25-Mar-2014 Joint Venture Biotechnology
Polfa Warszawa 19-Apr-2012 Merger/Acquisition Pharmaceuticals
Akrikhin Pharmaceuticals 28-Dec-2011 Secondary Transaction - Private Pharmaceuticals
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

Polpharma Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
Akrikhin Pharmaceuticals Moscow, Russia 1936
Biofarm Bucharest, Romania 1921
Santo (Pharmaceuticals) Shymkent, Kazakhstan 1881

Polpharma FAQs

  • When was Polpharma founded?

    Polpharma was founded in 1935.

  • Where is Polpharma headquartered?

    Polpharma is headquartered in Starogard Gdanski, Poland.

  • What is the size of Polpharma?

    Polpharma has 5,600 total employees.

  • What industry is Polpharma in?

    Polpharma’s primary industry is Pharmaceuticals.

  • Is Polpharma a private or public company?

    Polpharma is a Private company.

  • What is Polpharma’s current revenue?

    The current revenue for Polpharma is .

  • How much funding has Polpharma raised over time?

    Polpharma has raised $443M.

  • Who are Polpharma’s investors?

    Futurion 1 has invested in Polpharma.

  • Who are Polpharma’s competitors?

    Alkem Laboratories, Sun Pharmaceutical Industries, Protek (Distribution & Retail), Novartis, and Akrikhin Pharmaceuticals are some of the 15 competitors of Polpharma.

  • When was Polpharma acquired?

    Polpharma was acquired on 07-May-2024.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process